Objectives: To find preferences for treatment expressed by lupus patients and physicians (who were asked to assume they have lupus) and to explore if certain variables explain these preferences. Methods: One hundred seventy-two patients and 202 physicians were interviewed using a lupus nephritis decision board that describes the treatment options and their potential benefits and risks. Clinical and sociodemographic variables were collected. Participants were asked to indicate their preferred treatment and provide justification for their choice. Descriptive statistics, t tests, and Pearson's chi-square tests were used to determine the significance of differences in the decisions made by the two groups. A logistic regression model determined which factors contributed to treatment decisions. Results: The average age of study participants was 34 Ϯ 8 years for patients and 31 Ϯ 7 years for physicians. Sixty-eight percent of patients and 96% of physicians (P Ͻ 0.001) selected the oral option. Patients and physicians justified their choice of treatment using different arguments (P Ͻ 0.001 in each case). Logistic regression showed that risk potential (P Ͻ 0.001) and a history of joint involvement (P ϭ 0.011) were the arguments used most often to explain a patient's decision and the risk of side effects was most relevant among physicians (P Ͻ 0.001). Conclusions: Using a decision board, patients and physicians were found to have different preferences for treatment when faced with the same treatment options. Further, the variables that influence their preferences are different.
Introduction
The growing involvement of patients in their health care decisions has given them a more active role in the patient-physician relationship [1, 2] . Many studies have looked at this theme and show that different factors will influence patient preferences for their health care [3] [4] [5] [6] . Some studies have looked at the relevance of parameters such as pain, clinical history, socioeconomic context, and the willingness to accept the risk that clinical decisions might have adverse outcomes [6 -9] . Many authors have also pointed to discrepancies between patient and physician preferences in terms of the therapeutic handling of different diseases, including the techniques used to approach this point [10, 11] . These issues are parameters that must be looked at from the point of view of preference-based medicine [5] [6] [7] [8] [9] [10] [11] .
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease of varying progress and prognosis [12] . Lupus nephritis (LN) is the renal complication of SLE. It occurs in 40% to 60% of patients at some stage of the disease [12, 13] . Survival has increased in recent decades due to a better understanding of the mechanisms of the disease and the therapeutic arsenal available [12, 14] . The target of treatment is to promote remission of renal disease and impede its progression to endstage renal disease [12, 13] . All of the prognostic studies have identified LN as a predictor of a negative outcome [12] [13] [14] . Therapeutic handling of LN remains controversial due to the different risks and benefits resulting from the use of the immunosuppressive drugs available to treat LN [12] [13] [14] . Several studies have been exploring patient preferences on the context of lupus disease. However they usually do not use a decision tool to help the process of decision making [15] [16] [17] [18] [19] [20] [21] .
A decision support tool, such as a decision board (DB), displays a number of clinical issues and the consequences of each option to enable solving the issue using a process that is both standardized and free of bias [22] . The DB is a simple tool that displays more than one therapeutic option to be valued and decided on [22] [23] [24] [25] . It is low cost and can be easily updated.
The development and validating of a Brazilian DB for LN for patients in Brazil was the first step in our study and has been described in a previous article [24] . Although several studies have attempted to assess the existence of discrepancies between physician and patient preferences regarding the same health care issue, most have used physicians who specialize in the disease in question [15] [16] [17] [18] [19] [20] [21] . In our study, we deliberately did not use rheumatologists for the reasons explained in more detail below. The objectives of this study were: 1) to find out the preferences for treatment expressed by SLE patients and by physicians who were asked to assume that they themselves had SLE, when faced with two options to treat LN using the Brazilian DB for LN, and 2) to explore if certain variables explain these preferences and if these variables differ between the patients and the physicians.
Materials and Methods
This was a cross-sectional study [26] . Patients were selected consecutively on the date they were seen at a university tertiary hospital clinic, which is an authority in the country on the care of complex diseases like SLE. Over the period of one year, patients and physicians were invited to take part in the study.
Nonrheumatologist physicians were selected from the personnel files of the same institution. An Email message was sent to each of these physicians describing the nature of the study and inviting them to come in for an interview. Those who agreed to participate and met the criteria for selection were included in the study. Interviews with consenting physicians were scheduled during normal working hours at the hospital.
The following criteria were used to include patients: women between ages 18 and 50 years with a 12-month or longer diagnosis of SLE according to the modified classification criteria published by the American College of Rheumatology and any clinical manifestation of the disease. In addition, patients had to be able to read and write, according to their own statement, agree to participate in the study, and sign a statement of free and informed consent. Patients presenting active lupus psychosis or any form of cognitive disability that would make it difficult for them to understand the questionnaires were excluded, as were patients whose records were unavailable at the time of the interview.
The following criteria were used to include physicians: female academic physicians, practitioners, and physicians in training. Rheumatologists were excluded from the study to avoid a bias based on specific knowledge of the disease or the practices in the services they work for. We only recruited female physicians because the disease primarily affects women.
The LN DB was used during individual interviews [25] . The content was presented and added to during the course of the interview (Fig. 1) . At the beginning of the interview participants were given a summary presentation of the disease. Following this, they were given information on the treatment options (Option 1-oral treatment, or Option 2 -intravenous treatment), including methods of administration, the chances of remission, and a list of the eight most prevalent side effects described in the literature. We did not include the name of the drugs to avoid bias. Option 1 (oral) referred to therapy with mycophenolate mofetil, and Option 2 to therapy with intravenous cyclophosphamide. Study participants were asked to select the three side effects that most bothered them out of the list of eight. In the last phase of the DB, participants were told the probability of each of the selected side effects for each treatment option. Following the standard presentation, the content was reviewed and interviewees were asked to select one of the treatment options. After this they were asked to justify their decision based on a list of preselected alternatives. Justifica- 
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tions were classified under one of four options: risk, effectiveness, risk/benefit trade-off, and practicality. Risk justifications were those based on the probability of each of the three side effects for each treatment option. Effectiveness justifications were those where participants justified their treatment choice based on the probability of disease remission. Risk/benefit trade-off justifications were those where patients, when choosing their preferred option, tried to consider all of the characteristics of both treatment options (i.e., their potential risks and effectiveness). Practicality justifications were those where the most important factor in choosing the treatment was how the drug was administered and how it would affect the interviewee's day-to-day activities [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The methodology used to categorize the justifications was presented in an article on developing and validating the Brazilian LN DB [25] . Following the DB presentation, patients were asked to fill out the clinical and health related quality of life questionnaire. The clinical questionnaires used were Systemic Lupus Erythematosus Disease Activity Index [SLEDAI] [27] , and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC-DI) [28] . Health-related quality of life was assessed using the Medical Outcomes Study 36-Item ShortForm Health Survey (SF-36). Previous studies had already translated and tested the validity of the Portuguese language version of this tool [29, 30] . Socioeconomic variables were assessed using the Brazilian Economic Classification Criterion (BECC) questionnaire, a validated tool used to classify people into socioeconomic categories (ranging from A to E, with A being the highest) [31] . In our study we wanted to test the hypothesis that patients and physicians will choose different treatments for LN when presented with the same clinical scenario using the DB. This hypothesis was formulating based on the following premises: 1) the socioeconomic and cultural contexts are different for the physician and patient groups included in the study; and 2) physicians tend to have some technical information about the disease and a different frame of mind in term of understanding of diseases in general. By excluding rheumatologists we believe we came as close as possible to contrasting the medical approach with the lay person approach to assessing the value of a treatment.
Initially we assessed the preferences of each group for treatment (ie, choice of preferred treatment) following the DB presentation. We then tested if a statistical difference between treatment preferences exists, after which we tried to find out which variables might explain the treatment preferences of each group.
The following variables were used to test the hypothesis: 1) decision variables (i.e., side effects selected, treatment decision, and justification); 2) socioeconomic variables (i.e., income, the BECC, and years of schooling); 3) clinical variables (i.e., severity). In this study, we defined severity as two or more of the following: prior and/or current use of cyclophosphamide; prior and/or current use of other immunosuppressive agents; increased disease activity defined as an SLEDAI score of eight or more; and increased chronicity, defined as an SLICC-DI score of five or more. Severity was adopted as a dichotomous variable.
The project was approved by the Committee for Ethics in Research of our institution.
Statistical analysis
This study belongs to a larger one. We developed and tested a DB and a willingness-to-pay tool to assess strengh of preference. The sample was calculated based on prior similar studies and an equal distribution of the values to be offered in the willingness-to-pay survey. The estimated sample was 150 interviewees for each group [28, 32] . The descriptive analysis summarizes the qualitative and quantitative variables as appropriate. Patient and physician results were compared using Pearson's chi-square and Student t tests [32] . For the purposes of this analysis, side effects were grouped into risk of death that was also presented as a dichotomous variable (yes/no).
Univariate analyses were completed to identify associations between variables and LN treatment decisions. Logistic regression analyses assessed which factors influence the treatment decision in each group. We assumed that Option 1 and Option 2 are the dependent variables. As explanatory variables we included side effects, justification for the option selected, socioeconomic variables, years of schooling, clinical severity variables (yes/no), and quality of life (SF-36 domains) [32, 33] . Only associations found to be significant with univariate analyses were included in the logistic regression [30, 31] . For all statistical tests we considered a level of significance of 5% or lower [32, 33] . All of the statistical analyses were conducted using SPSS version 13.0 (SPSS Inc., Chicago, IL).
Results
We interviewed 172 patients and 202 physicians during 1 year. The average age was 34 Ϯ 8 years for patients and 31 Ϯ 7 years for physicians. All of the patients approached agreed to participate in the study and 8% of the physicians approached refused, all of them in training and claiming not to have time to participate. Everyone who participated in the survey provided data. Most of the patient group was made up of mulatto (i.e., Brazilian mixed race [35, 36] ) persons (45%) and most of the physician group (67%) was white. Demographic, quality of life, and clinical characteristics are described in Tables 1, 2 , and 3, respectively. Regarding the BECC distribution, 76% of patients were classified as C and D and 18% as B2. In the physician group, the BECC distribution was class A2 (33.2%), followed by B1 (24.8%), and A1 (20.3%) ( Table 1 ). All of the SF-36 domain scores were lower for patients than physicians (P Ͻ 0.001 for each comparison). The average time spent on the DB was 20 Ϯ Table 4 . Option 1 was the preferred treatment choice by 68% of patients and 98% of physicians (P Ͻ 0.001). Patients and physicians justified their decision based on risk (47.7% and 68.9%), effectiveness (12.2% and 2.0%), risk/benefit trade-offs (2.3% and 22.3%), and practicality (37.8% and 5.9%). Analyses show these differences are statistically significant in each case (P Ͻ 0.001) ( Table 4 ). Based on a univariate analysis, the variables selected for the multivariate patient model were: cancer, severe infection, decision justification, SLEDAI, skin involvement, joint involvement, maternity (yes/ no), number of inhabitants, socioeconomic class, income, and SF-36. The final model was adjusted excluding variables step by step to arrive at a reduced model. Multivariate analysis shows that patient decisions were guided primarily by the potential risk posed by the drug, represented by a risk based justification, compared to an effectiveness-based justification (P Ͻ 0.001; odds ratio 31.8; 95% confidence interval 8.2-122.9) or a practicality based justification (P Ͻ 0.001); OR 6.0; 95% CI 2.5-14.2). Patients with prior joint involvement were less likely to select Option 1, compared with patients with no joint involvement (P ϭ 0.011; OR 5.3; 95% CI 1.4 -19.5) ( Table 5 ).
In the physician group, the same explanatory variables were used to build the univariate model, with the exception of the clinical variables. This model showed that physicians who justified their decision based on risk tended to select Option 1, compared to 
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those who made their decision based on practicality (P ϭ 0.007), OR 64; 95% CI 3.1-1332). (See Table 5 .) Age can also influence the decision: the older the study participant the more likely she was to select Option 1 (P ϭ 0.08; OR 2.28; 95% CI 0.88 -5.8).
Discussion
This study addresses the preferences for treatment of two different groups facing the same scenario. Both groups consisted of individuals of the same sex and of a similar age group. The other demographic characteristics are different for the two groups, among them socioeconomic level and BECC scores (Table 1 ) [31] . The health-related quality of life profile also yielded different results for both groups. The patient group had the lowest SF-36 scores in all domains, probably as a result of the disease itself (Table 2 ). Because the institution was a tertiary center, the severity of the disease reflected this, as shown in Table 3 . The two groups selected different side effect as being more important (Table 4) . Regarding the treatment options, both groups tended to prefer Option 1. Results showed that the decisions were based on different justifications (P Ͻ 0.001), which were a reflection of what is important for each interviewee when making treatment decisions (Table 5) .
We asked physician to imagine they were patients (i.e., to imagine that they have LN). This strategy has strengths and limitations. The strengths lie in the fact that, by considering themselves patients, potentially the physicians will make their decisions from the point of view of a patient. Different from other studies that have assessed the preference of physicians and patients, we tried to assess the physician choice, encouraging them to place themselves on the other side and make their decisions accordingly [15] [16] [17] [18] [19] [20] [21] . By excluding rheumatologists, we avoid decisions that are influenced by clinical practice and well known evidence. In this way, we can elicit physician preferences and understand how they make their own health care decisions. This information may help us understand how medical knowledge and training can influence choices. This in turn can contribute to the design of education strategies that can help both patients and physicians communicate and deliberate while attempting to choose the best treatment for the patient [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] .
This study was structured to simulate the practical clinical reality of the institution where it was developed. A previous study done in Brazil explored patients' and physicians' perceptions about rheumatoid arthritis care. A study by Ferraz et al. [34] observed that patient and rheumatologists had different opinion about the health care provided. This study had a limitation that the answers provided by the rheumatologists who participated in the study were based on the guidelines used during that period of time rather than on what really happened [18 -21,34] .
A limitation of our study is that decisions made based on a hypothetical scenario may not necessarily reflect the decisions that would be made in a real situation. We believe, however, that the strengths outweigh the potential limitation. In addition, patients included in the study faced a hypothetical situation because knew they were making a decision as part of a scenario, and not an actual decision regarding their own treatment. This being the case, both groups faced hypothetical situations [15] [16] [17] [18] [19] [20] [21] .
Regarding the side effects chosen, although the side effect most often selected as being the worst was cancer by both groups (44% for patients and 45% for physicians), the rest were quite different (P Ͻ 0.001). We still do not understand the factors that could influence these decisions [25] . Other studies that assess patient preferences suggest similar results, although none made use of a support tool. There is a need for studies to explore this area [25] .
As a measure of agreement between patients and physicians, Kappa test was used to compare both groups' choices regarding the three side effects chosen and the final decision. For the three side effects chosen, Kappa results were 0.334, 0.202, and 0.220 (P Ͻ 0.001), respectively. In respect to the final decision, Kappa coefficient was 0.757 (P Ͻ 0.001).
Both groups tended to prefer Option 1. This was, however, stronger among physicians and it was statistically significant (98% vs. 68% for patients; P Ͻ0.001). There are also significant differences in their justifications (P Ͻ 0.001). Also, this study showed that both groups have in common the fact that the variable "decision justification" was the one that best explained the decision regarding treatment options. It can allow us to reflect that, even if the justifications used by the two groups were different, their influence on the decisions made reflect their concerns regarding the potential consequences of these decisions. These findings also show that different factors influence patient and physician decisions, as shown in the decision justifications [26, [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] , and may be one of the factors explaining the miscommunication observed in patient-physician encounters [35, 36, [43] [44] [45] . Regarding the other factors that influence preferences, study results also show that joint involvement and possibly socioeconomic class influence patient treatment decisions. These variables may reflect the impact of the chronic nature and how this influences patient decisions. This interpretation is speculative. The variables that explain what influences patient preferences are far from being completely understood and further research is called for to explore this issue. Among physicians, household income and BECC scores did not influence treatment decision. These data may reflect the homogeneous socioeconomic and cultural character of this group compared to the patient group, which is socioeconomically more diverse and made up predominantly of persons in socioeconomic categories C, D, and E [31] . One issue that may have influenced this group's decision was the likelihood of the selected side effects. This strategy enabled making up a scenario of a severity proportional to the events mentioned [37] [38] [39] [40] [41] . Our results show that physician and patient decisions are influenced by different factors, leading to potential discrepancies when facing the same issue to be assessed, namely the treatment of LN. Considering the chronic nature of SLE and its clinical peculiarities, we must question if such differences compromise communication between physician and patient in clinical practice, leading to poor treatment compliance [37] [38] [39] [40] [41] [42] [43] [44] [45] .
Conclusions
Physician and patient decisions are influenced by different factors, leading to potential discrepancies when facing the same issue to be assessed. Treatment choice has to be discussed with patients, because individual preference seems to be determined by personal attitudes toward safety and convenience, by past experience, and by the perception of current disease status.
